These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 35696319)

  • 1. Chrysin-Loaded Chitosan Nanoparticle-Mediated Neuroprotection in Aβ
    Saleem S; Banerjee R; Rajesh Kannan R
    ACS Chem Neurosci; 2022 Jul; 13(13):2017-2034. PubMed ID: 35696319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of optogenetic Amyloid-β distinguishes between metabolic and physical damages in neurodegeneration.
    Lim CH; Kaur P; Teo E; Lam VYM; Zhu F; Kibat C; Gruber J; Mathuru AS; Tolwinski NS
    Elife; 2020 Mar; 9():. PubMed ID: 32228858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitigating effect of chrysin loaded solid lipid nanoparticles against Amyloid β25-35 induced oxidative stress in rat hippocampal region: An efficient formulation approach for Alzheimer's disease.
    Vedagiri A; Thangarajan S
    Neuropeptides; 2016 Aug; 58():111-25. PubMed ID: 27021394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current Insights of Nanocarrier-Mediated Gene Therapeutics to Treat Potential Impairment of Amyloid Beta Protein and Tau Protein in Alzheimer's Disease.
    Jain U; Johari S; Srivastava P
    Mol Neurobiol; 2024 Apr; 61(4):1969-1989. PubMed ID: 37831361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sialic acid (SA)-modified selenium nanoparticles coated with a high blood-brain barrier permeability peptide-B6 peptide for potential use in Alzheimer's disease.
    Yin T; Yang L; Liu Y; Zhou X; Sun J; Liu J
    Acta Biomater; 2015 Oct; 25():172-83. PubMed ID: 26143603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chitosan oligosaccharides protect rat primary hippocampal neurons from oligomeric β-amyloid 1-42-induced neurotoxicity.
    Dai X; Chang P; Zhu Q; Liu W; Sun Y; Zhu S; Jiang Z
    Neurosci Lett; 2013 Oct; 554():64-9. PubMed ID: 23999027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoparticle-mediated approaches for Alzheimer's disease pathogenesis, diagnosis, and therapeutics.
    Hettiarachchi SD; Zhou Y; Seven E; Lakshmana MK; Kaushik AK; Chand HS; Leblanc RM
    J Control Release; 2019 Nov; 314():125-140. PubMed ID: 31647979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
    Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
    Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Biodegradable, Chitosan-Based Nanoparticles in the Treatment of Alzheimer's Disease.
    Manek E; Darvas F; Petroianu GA
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33096898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced neuroprotection of anthocyanin-loaded PEG-gold nanoparticles against Aβ
    Kim MJ; Rehman SU; Amin FU; Kim MO
    Nanomedicine; 2017 Nov; 13(8):2533-2544. PubMed ID: 28736294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual-functional nanoparticles for precise drug delivery to Alzheimer's disease lesions: Targeting mechanisms, pharmacodynamics and safety.
    Zheng X; Zhang C; Guo Q; Wan X; Shao X; Liu Q; Zhang Q
    Int J Pharm; 2017 Jun; 525(1):237-248. PubMed ID: 28432017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anthocyanin-Loaded PEG-Gold Nanoparticles Enhanced the Neuroprotection of Anthocyanins in an Aβ
    Ali T; Kim MJ; Rehman SU; Ahmad A; Kim MO
    Mol Neurobiol; 2017 Oct; 54(8):6490-6506. PubMed ID: 27730512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain targeting based nanocarriers loaded with resveratrol in Alzheimer's disease: A review.
    Jalili C; Kiani A; Gholami M; Bahrehmand F; Fakhri S; Kakehbaraei S; Kakebaraei S
    IET Nanobiotechnol; 2023 May; 17(3):154-170. PubMed ID: 36949020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening of Synthetic Isoxazolone Derivative Role in Alzheimer's Disease: Computational and Pharmacological Approach.
    Ali M; Saleem U; Anwar F; Imran M; Nadeem H; Ahmad B; Ali T; Atta-Ur-Rehman ; Ismail T
    Neurochem Res; 2021 Apr; 46(4):905-920. PubMed ID: 33486698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Synthetic Pro-Drug Peptide Reverses Amyloid-β-Induced Toxicity in the Rat Model of Alzheimer's Disease.
    Kumar S; Srivastav S; Fatima M; Giri RS; Mandal B; Mondal AC
    J Alzheimers Dis; 2019; 69(2):499-512. PubMed ID: 30958369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic chrysin silica nanomaterials behavior in an amyloidogenic environment.
    Nday CM; Eleftheriadou D; Jackson G
    Hell J Nucl Med; 2019; 22 Suppl():42-50. PubMed ID: 30877722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Memantine loaded PLGA PEGylated nanoparticles for Alzheimer's disease: in vitro and in vivo characterization.
    Sánchez-López E; Ettcheto M; Egea MA; Espina M; Cano A; Calpena AC; Camins A; Carmona N; Silva AM; Souto EB; García ML
    J Nanobiotechnology; 2018 Mar; 16(1):32. PubMed ID: 29587747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-truncated Abeta starting with position four: early intraneuronal accumulation and rescue of toxicity using NT4X-167, a novel monoclonal antibody.
    Antonios G; Saiepour N; Bouter Y; Richard BC; Paetau A; Verkkoniemi-Ahola A; Lannfelt L; Ingelsson M; Kovacs GG; Pillot T; Wirths O; Bayer TA
    Acta Neuropathol Commun; 2013 Sep; 1():56. PubMed ID: 24252153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chrysin loaded lipid-core nanocapsules ameliorates neurobehavioral alterations induced by β-amyloid
    Giacomeli R; de Gomes MG; Reolon JB; Haas SE; Colomé LM; Jesse CR
    Behav Brain Res; 2020 Jul; 390():112696. PubMed ID: 32417280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanistic comparison of current pharmacological treatments and novel phytochemicals to target amyloid peptides in Alzheimer's and neurodegenerative diseases.
    Ayyalasomayajula N; Suresh C
    Nutr Neurosci; 2018 Dec; 21(10):682-694. PubMed ID: 28683598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.